Subramanyan R, Joy J, Balakrishnan K G
Department of Cardiology, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.
Circulation. 1989 Sep;80(3):429-37. doi: 10.1161/01.cir.80.3.429.
The natural history of aortoarteritis was studied in 88 patients (54 women and 34 men). The average age was 24.0 +/- 8.8 years at onset of symptoms and 28.3 +/- 9.9 years at diagnosis. The follow-up period was 83.6 +/- 74.4 months from onset and 33.2 +/- 37.0 months from diagnosis. Ten patients (11.4%) died during follow-up (0.016 deaths/patient year), and 22 patients (25%) suffered major nonfatal events (0.042 events/patient year). The cumulative survival at 5 and 10 years after the onset was 91.0 +/- 3.3% and 84.0 +/- 5.6% (mean +/- SEM), respectively. The event-free survival rates at the same intervals after onset were 74.9 +/- 5.0% and 64.0 +/- 7.4%, respectively. The overall survival and event-free survival at 10 years after diagnosis was 80.3 +/- 6.5% and 61.6 +/- 7.5%, respectively. Patients with no complications or a mild single complication at diagnosis had a higher event-free survival rate than those with severe single complication or multiple complications at 5 years--97.0 +/- 2.9% and 59.7 +/- 7.3%, respectively (p less than 0.001). Severe hypertension (p less than 0.01), severe functional disability (p less than 0.01), and evidence of cardiac involvement (p less than 0.05) were good predictors of either death or major event on follow-up. These data are useful in making an objective assessment of the prognosis and in planning elective interventions.
对88例患者(54例女性和34例男性)的大动脉炎自然病史进行了研究。症状出现时的平均年龄为24.0±8.8岁,诊断时为28.3±9.9岁。从症状出现起的随访期为83.6±74.4个月,从诊断起为33.2±37.0个月。10例患者(11.4%)在随访期间死亡(0.016例死亡/患者年),22例患者(25%)发生重大非致命事件(0.042例事件/患者年)。症状出现后5年和10年的累积生存率分别为91.0±3.3%和84.0±5.6%(均值±标准误)。症状出现后相同时间间隔的无事件生存率分别为74.9±5.0%和64.0±7.4%。诊断后10年的总生存率和无事件生存率分别为80.3±6.5%和61.6±7.5%。诊断时无并发症或仅有轻度单一并发症的患者,其5年无事件生存率高于有严重单一并发症或多种并发症的患者,分别为97.0±2.9%和59.7±7.3%(p<0.001)。严重高血压(p<0.01)、严重功能障碍(p<0.01)和心脏受累证据(p<0.05)是随访中死亡或重大事件的良好预测指标。这些数据有助于对预后进行客观评估并规划选择性干预措施。